Publication date: Aug 26, 2019
Big data problems are becoming more prevalent for laboratory scientists who look to make clinical impact. A large part of this is due to increased computing power, in parallel with new technologies for high quality data generation. Both new and old techniques of artificial intelligence (AI) and machine learning (ML) can now help increase the success of translational studies in three areas: drug discovery, imaging, and genomic medicine. However, ML technologies do not come without their limitations and shortcomings. Current technical limitations and other limitations including governance, reproducibility, and interpretation will be discussed in this article. Overcoming these limitations will enable ML methods to be more powerful for discovery and reduce ambiguity within translational medicine, allowing data-informed decision-making to deliver the next generation of diagnostics and therapeutics to patients quicker, at lowered costs, and at scale.
Open Access PDF
Toh, T.S., Dondelinger, F., and Wang, D. Looking beyond the hype: Applied AI and machine learning in translational medicine. 05282. 2019 EBioMedicine.
|Artificial Intelligence||Translational medicine|
|Drug Discovery||Artificial intelligence|
- Contributions from the 2018 Literature on Bioinformatics and Translational Informatics.
- Maxwell®: An Unsupervised Learning Approach for 5P Medicine.